For the quarter ended June 2026, Charles River Laboratories (CRL Quick QuoteCRL - Free Report) reported revenue of $1 billion, down 2.7% over the same period last year. EPS came in at $3.02, compared to $3.12 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $970.77 million, representing a surprise of +3.43%. The company delivered an EPS surprise of +11.03%, with the consensus EPS estimate being $2.72.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Charles River performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenue- Research Models and Services: $209.48 million versus $199.8 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -1.8% change.
• Revenue- Manufacturing Solutions: $188.1 million compared to the $185.04 million average estimate based on three analysts. The reported number represents a change of -6.3% year over year.
• Revenue- Discovery and Safety Assessment: $606.51 million versus the three-analyst average estimate of $582.7 million. The reported number represents a year-over-year change of -1.9%.
• Operating income- Manufacturing Solutions- Non-GAAP: $71.15 million versus the three-analyst average estimate of $55.38 million.
• Operating income- Discovery and Safety Assessment- Non-GAAP: $155.32 million compared to the $149.55 million average estimate based on three analysts.
• Operating income- Research Models and Services- Non-GAAP: $51.25 million versus the three-analyst average estimate of $50.04 million.
• Operating income- Discovery and Safety Assessment: $124.4 million versus $123.97 million estimated by two analysts on average.
• Operating income- Research Models and Services: $36.28 million compared to the $31.2 million average estimate based on two analysts.
• Operating income- Manufacturing Solutions: $65.61 million versus $44.17 million estimated by two analysts on average.
• Operating income- Unallocated Corporate Overhead: $-106.39 million versus the two-analyst average estimate of $-65.34 million.

View all Key Company Metrics for Charles River here>>>

Shares of Charles River have returned +2.4% over the past month versus the Zacks S&P 500 composite's +3.5% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.